Andrew C Stone1, Jennifer J Carroll2, Josiah D Rich3, Traci C Green2. 1. Discovery House Comprehensive Treatment Center, 1625 Diamond Hill Road, Woonsocket, RI 02895, USA. Electronic address: ACStoneMD@gmail.com. 2. The Warren Alpert School of Medicine of Brown University, Rhode Island Hospital, Department of Emergency Medicine, 55 Claverick Street, Providence, RI 02903, USA. 3. Brown University and The Center for Prisoner Health and Human Rights, The Miriam Hospital, 164 Summit Ave, Providence, RI 02906, USA.
Abstract
INTRODUCTION: Illicitly manufactured fentanyl (IMF) is a potent synthetic opioid that has been contributing to overdose deaths in the United States. This study examined intake toxicology and six-month treatment outcomes for patients newly admitted to a single methadone maintenance treatment program (MMTP) in Rhode Island with a high prevalence of illicit fentanyl. METHODS: We conducted a retrospective chart review of patients admitted to a single MMTP between November 1st, 2016 and August 31st, 2017 followed for six months. Outcomes measured included: 1) retention in treatment at 6 months; 2) evidence of sustained abstinence; 3) relapse; 4) methadone dosage required to achieve sustained abstinence; and 5) the number of days required to achieve abstinence. RESULTS: We observed 154 unique intake events (representing 147 patients). 80% (n = 123) tested positive for fentanyl at intake. During the six-month follow up period, 32% (n = 49) left treatment before six months, two individuals died within five weeks of discontinuation. No deaths were seen among those remaining in treatment. The majority (89%) who remained in treatment at six months achieved abstinence. No significant difference was seen for dose or time to achieve abstinence. Relapse was common (57%). Repeated exposure to fentanyl was seen frequently (71%) while in MMT before and after achieving abstinence. CONCLUSION: While there is concern that the potency of IMF may reduce the effectiveness of MAT, this study suggests that MMT is safe, abstinence achievable, and MMT is protective against death among fentanyl-exposed patients.
INTRODUCTION: Illicitly manufactured fentanyl (IMF) is a potent synthetic opioid that has been contributing to overdose deaths in the United States. This study examined intake toxicology and six-month treatment outcomes for patients newly admitted to a single methadone maintenance treatment program (MMTP) in Rhode Island with a high prevalence of illicit fentanyl. METHODS: We conducted a retrospective chart review of patients admitted to a single MMTP between November 1st, 2016 and August 31st, 2017 followed for six months. Outcomes measured included: 1) retention in treatment at 6 months; 2) evidence of sustained abstinence; 3) relapse; 4) methadone dosage required to achieve sustained abstinence; and 5) the number of days required to achieve abstinence. RESULTS: We observed 154 unique intake events (representing 147 patients). 80% (n = 123) tested positive for fentanyl at intake. During the six-month follow up period, 32% (n = 49) left treatment before six months, two individuals died within five weeks of discontinuation. No deaths were seen among those remaining in treatment. The majority (89%) who remained in treatment at six months achieved abstinence. No significant difference was seen for dose or time to achieve abstinence. Relapse was common (57%). Repeated exposure to fentanyl was seen frequently (71%) while in MMT before and after achieving abstinence. CONCLUSION: While there is concern that the potency of IMF may reduce the effectiveness of MAT, this study suggests that MMT is safe, abstinence achievable, and MMT is protective against death among fentanyl-exposed patients.
Authors: Anneli Uusküla; Ave Talu; Sigrid Vorobjov; Maris Salekešin; Jürgen Rannap; Liis Lemsalu; Don Des Jarlais Journal: Int J Drug Policy Date: 2020-05-13
Authors: Jan Gryczynski; Helen Nichols; Robert P Schwartz; Shannon Gwin Mitchell; Paulette Hill; Kim Wireman Journal: Drug Alcohol Depend Date: 2019-08-30 Impact factor: 4.492
Authors: Xiaoyan Fan; Xiao Zhang; Huifang Xu; Fan Yang; Joseph T F Lau; Chun Hao; Jinghua Li; Yuteng Zhao; Yuantao Hao; Jing Gu Journal: Int J Environ Res Public Health Date: 2019-11-07 Impact factor: 3.390